Neurosterix

Private

GenevaHealthcare & Life Scienceshttps://neurosterix.com/

Last Round

Series A

Apr 3, 2024

Est. Valuation

$98M

Total Funding Raised

$65M

Company Overview

Neurosterix is a biopharmaceutical company that develops allosteric modulator therapeutics for the treatment of neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

allosteric modulatorM4 PAMschizophrenia drugclinical-stage biotechdrug discoveryneurological disordersbiotech spin-outCNS therapeuticspositive allosteric modulatorsmall-molecule drugneuroscience startupclinical pipelinepharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurosterix Comps

Public and private peers based on sector, stage, and business model.

Neurosterix comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurosterix Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Apr 3, 2024

View all Funding Rounds

Neurosterix Investors

Notable investors and investment history

Neurosterix investors
Investor	Rounds
Perceptive Advisors	Series A
Xontogeny	Series A
Acorn Bioventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 2, 2024
$65M round led by Perceptive Advisors and Xontogeny

View all signals

Neurosterix Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Neurosterix Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurosterix's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeneva

Employee Range29

Year Founded2024

Last FundingApr 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.